Doris O. Matsui

To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.

Emergency Reporting Act

This bill, known as the Emergency Reporting Act, addresses Emergency Reporting Act. It has been introduced and awaits committee review.

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

This bill, known as the To amend title XVIII of the Social Security Act, proposes to amend the title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary. It has been referred to committee for review and possible markup.

Kari's Law Reporting Act

This bill, known as the Kari's Law Reporting Act, addresses Kari's Law Reporting Act. It has been introduced and awaits committee review.

Reversionary Interest Conveyance Act

This bill, known as the Reversionary Interest Conveyance Act, addresses Reversionary Interest Conveyance Act. It has been introduced and awaits committee review.

Whale CHARTS Act of 2026

This bill, known as the Whale CHARTS Act of 2026, addresses Whale CHARTS Act of 2026. It has been referred to committee for review and possible markup.

Senior Savings Protection Act

340B PATIENTS Act of 2025

This bill, known as the B PATIENTS Act of 2025, addresses 340B PATIENTS Act of 2025. It has been referred to committee for review and possible markup.

Climate Change Health Protection and Promotion Act of 2025

This bill, known as the Climate Change Health Protection and Promotion Act of 2025, addresses Climate Change Health Protection and Promotion Act of 2025. It has been referred to committee for review and possible markup.

Diesel Emissions Reduction Act of 2025